Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:21 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3433–3456 of 4,968 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Accepts healthy volunteers Clear all

Conditions: Healthy Subjects
Interventions: Ultrasound stimulation intensity, Ultrasound stimulation site; Device
Lead sponsor: University of Virginia; Other
Eligibility: 25 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Attention-deficit/Hyperactivity Disorder, ADHD
Interventions: RAMP Reports, Digital Education Handouts; Other
Lead sponsor: IDeA States Pediatric Clinical Trials Network; Network
Eligibility: 5 Years to 11 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Jackson, Mississippi • Charleston, South Carolina

Conditions: Myopia
Interventions: Atropine Sulfate 0.05% Oph Soln, Placebo; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 6 Years to 11 Years
Enrollment: 664 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 13
States / cities: Birmingham, Alabama • Berkeley, California • Fullerton, California + 10 more

Conditions: Postoperative Ileus
Interventions: Pyridostigmine Bromide, Placebo; Drug · Other
Lead sponsor: Stefan Holubar MD MS FACS, FASCRS; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Polyp, Colorectal Adenocarcinoma, Colorectal Disorders, Colorectal Dysplasia, Colorectal Cancer Stage I, Colorectal Cancer Stage II, Colorectal Cancer Stage III, Colorectal Cancer Stage IV, Colorectal Neoplasms Malignant, Colorectal Serrated Adenocarcinoma, Colorectal Adenoma With Severe Dysplasia, Colorectal Adenoma With Mild Dysplasia, Colorectal Adenoma With Moderate Dysplasia, Colorectal Adenoma and Carcinoma 1, Colorectal Adenomatous Polyp, Colorectal Adenocarcinoma Metastatic in the Liver
Interventions: DENEB; Diagnostic Test
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 2
States / cities: Monrovia, California • San Diego, California

Conditions: Cancer Diagnosis
Interventions: GRAIL Galleri; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 45 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Smart Eyewear
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Uterine Septum, Surgical Complication, Septum; Uterus, Treatment Side Effects, Treatment
Interventions: Removal of uterine septum with hysteroscopic scissors without electrosurgery., Hysteroscopic septoplasty utilizing bipolar electrosurgery; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 22 Years to 44 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cushing Disease
Interventions: Fimepinostat; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alcohol Use Disorder, Alcohol Use, Unspecified, Heavy Drinker, Alcohol Use Disorder, Moderate, in Sustained Remission
Interventions: Deuterium Metabolic Imaging with deuterated acetate tracer; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Stroke, Aphasia, Language
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 85 Years
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2032
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Ulcerative Colitis (UC)
Interventions: XmAb942, Placebo; Biological · Drug
Lead sponsor: Xencor, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 31
States / cities: Scottsdale, Arizona • Palo Alto, California • Bradenton, Florida + 25 more

Conditions: Kidney Neoplasm
Interventions: Not listed
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years to 100 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Smoking Cessation
Interventions: culturally tailored, trauma-informed mindfulness smoking cessation intervention; Behavioral
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Rapid City, South Dakota

Conditions: Stress and Memory in Adolescence
Interventions: Acute stress manipulation; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 12 Years to 18 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Irvine, California

Conditions: CBD, Cannabidiol, Stress, Acute Stress Reaction
Interventions: Stress Intervention; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years to 70 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Alcohol Abuse, Alcohol Use Disorder, Alcohol Drinking, Relations, Interpersonal, Military Family
Interventions: CRAFT Web-Based Intervention, Phone-Based CRAFT, CRAFT Workbook, Gottman Self-Guided Resources; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 744 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Food Preferences, Food Selection, Eating, Healthy, Obesity, Childhood
Interventions: Healthy Eating Curriculum, Improving the Classroom Food and Mealtime Environment, Parent Education, ECE Food Acceptance Training; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 3 Years to 6 Years
Enrollment: 770 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Human Papilloma Virus
Interventions: Not listed
Lead sponsor: Atila Biosystems Inc.; Industry
Eligibility: 30 Years to 64 Years · Female only
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Sunnyvale, California

Conditions: Digestion-associated Quality of Life
Interventions: Placebo GI Health Control, Active GI Health Product 1; Dietary Supplement
Lead sponsor: Radicle Science; Industry
Eligibility: 21 Years to 105 Years
Enrollment: 550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Del Mar, California

Conditions: Tobacco Use, Substance Use Disorders
Interventions: Switching to E-Cigarette, Quitting using Medication, Counseling; Behavioral · Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 4
States / cities: Charleston, South Carolina • Conway, South Carolina • Greenville, South Carolina + 1 more

Conditions: Systemic Scleroderma, Diffuse Cutaneous Scleroderma
Interventions: Spatial-frequency domain imaging (SFDI); Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: AKI (Acute Kidney Injury) Due to Trauma
Interventions: Sodium Bicarbonate (NaHCO3), Placebo; Dietary Supplement
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Severe Renal Impairment, Healthy
Interventions: Nemtabrutinib; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami Lakes, Florida

Search by objective public record fields.

Optimizing Ultrasound-induced Anti-inflammation in Human Subjects

A Pilot Study of a Remote ADHD Monitoring Program

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery

Early Detection of Advanced Adenomas and Colorectal Cancer

Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study

Smart Eyewear to Automatically Detect Drug Delivery Events

Surgical Approach to Uterine Septum

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Drinking, Acetate, and Stress

Language Processing and TMS

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry

Healing Within: Mindfulness Smoking Cessation Intervention

My Life and My Experiences Project

Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners

Increasing Food Literacy in Preschoolers to Reduce Obesity Risk

Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling

Radicle GI Health RAATM: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal-Related Quality of Life and Related Health Outcomes

STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

Acute Kidney Injury and Ultra-endurance Running

A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)